We are considering side effects to be work-related for any mandatory vaccine. We treat the employee in our internal Employee Health Dept under worker’s comp.

Lora S. Regan, MD, MPH, FACOEM
Medical Director, Corporate Health

Department of Occupational Medicine

Lancaster Office Lebanon Office

2110 Harrisburg Pike Suite 21 1701 Cornwall Road

Lancaster, PA 17604 Lebanon, PA 17042

(717) 544-3155 Patient Appointments
(717) 544-3161 Private line
(717) 544-3167 Secure Fax

From: MCOH-EH <mcoh-eh-bounces@mylist.net> On Behalf Of Enass Awad
Sent: Thursday, September 30, 2021 1:23 AM
To: MCOH-EH <mcoh-eh@mylist.net>
Subject: [External] Re: [MCOH-EH] FW: [MARKETING] [EXTERNAL] Reminder: CDC COCA Call Today: What Clinicians Need to Know About the Latest CDC Recommendations for Pfizer-BioNTech COVID-19 Booster Vaccination

Good evening MCOH-EH:

A question to those of you who are mandating COVID-19 vaccine on your employees.

Are you taking adverse effects of the vaccine as a work-related injury since the employees were REQUIRED to take it , and which was OSHA’s initial position ?

Or are you following the latest position from May where it was determined that regardless of whether it was recommended or required, and until at least May 2022, side effects are not to be considered as work-related ?

Thanks much ,

Enass Arahman, MD, MPH, FACOEM

On Wed, Sep 29, 2021 at 11:09 Thanassi, Wendy via MCOH-EH <mcoh-eh@mylist.net> wrote:

Just started! Jump on if you’re interested.

Wendy

Wendy Thanassi MA, MD, MRO

Chief, Occupational Health Service

Palo Alto VA Health Care System

cell 650-650-380-1131

Associate Professor, Affiliated

Epidemiology and Population Health Sciences

BC: Emergency Medicine

Stanford Hospital and Clinics

Stanford, CA 94305

From: Centers for Disease Control and Prevention <no-reply@emailupdates.cdc.gov>
Sent: Tuesday, September 28, 2021 7:12 AM
To: Knighton, V. Troy <troy.knighton@va.gov>
Subject: [MARKETING] [EXTERNAL] Reminder: CDC COCA Call Today: What Clinicians Need to Know About the Latest CDC Recommendations for Pfizer-BioNTech COVID-19 Booster Vaccination

What Clinicians Need to Know About the Latest CDC Recommendations for Pfizer-BioNTech COVID-19 Booster Vaccination

Overview

This COCA Call will give clinicians an overview of the Pfizer-BioNTech COVID-19 booster vaccination. Clinicians will learn about the vaccine booster recommendations, safety of booster dose, and clinical guidance for using the Pfizer-BioNTech COVID-19 booster vaccine.

If you are unable to attend the live COCA Call, the recording will be available for viewing on the COCA Call webpage a few hours after the live event ends.

The slide set will be available on the day of the call on the COCA Call webpage under "Call Materials".

CE will not be offered for this COCA Call.

Registration is not required.

Date: Tuesday, September 28, 2021

Time: 2:00 PM – 3:00 PM ET

A few minutes before the webinar starts, please click on the Zoom link below to join:

https://www.zoomgov.com/j/1602551375?pwd=MlllclovakpROFZBU1pYNmlIZE1Ydz09

Passcode: 163147

Or Telephone:

Dial(for higher quality, dial a number based on your current location):

US: +1 669 254 5252 or +1 646 828 7666 or +1 669 216 1590 or +1 551 285 1373

Or One-tap mobile:
US: +16692545252,,1602551375#,,,,*163147# or +16468287666,,1602551375#,,,,*163147#

Webinar ID: 160 255 1375

International numbers available: https://www.zoomgov.com/u/azlZAVzR

COCA Call Objectives

At the conclusion of the session, the participant will be able to accomplish the following—

Cite background information on the topic covered during the presentation.
Discuss CDC’s role in the topic covered during the presentation.
Describe the topic’s implications for clinicians.
Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.

Presenters

Dr. Ruth Link-Gelles, PhD, MPH

Co-lead COVID-19 Vaccine Effectiveness Team

Epidemiology Task Force

COVID-19 Response

Centers for Disease Control and Prevention

Dr. Anne Hause, PhD, MSPH

Co-Lead V-safe Team

Vaccine Task Force

COVID-19 Response

Centers for Disease Control and Prevention

Dr. Neela Goswami, MD, MPH

Lead Clinical Guidelines Team

Vaccine Task Force

COVID-19 Response

Centers for Disease Control and Prevention

The Emergency Risk Communication Branch in the Division of Emergency Operations, Center for Preparedness and Response is responsible for the management of all COCA products.

For information about this update or other clinical issues, or to send your feedback, please contact us at coca@cdc.gov

CDC Clinician Outreach and Communication Activity Facebook page—connect with COCA on Facebook
Clinician Outreach and Communication Activity—resources for healthcare providers
COCA RSS Feed—subscribe to be notified of conference calls, updates, and CDC guidance for health providers
Crisis & Emergency Risk Communication Training—training program that draws from lessons learned during public health emergencies, and incorporates best practices from the fields of risk and crisis communication
Health Alert Network—CDC's primary method of sharing cleared information about urgent public health incidents with public information officers; federal, state, territorial, and local public health practitioners; clinicians; and public health laboratories

CDC and HHS logos are the exclusive property of the Department of Health and Human Services and may not be used for any purpose without prior express written permission. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

Links to non-federal organizations are provided solely as a service to our users. Links do not constitute an endorsement of any organization by CDC or the federal government, and none should be inferred. CDC is not responsible for the content of the individual organizations.

Centers for Disease Control and Prevention

1600 Clifton Rd Atlanta, GA 30329 1-800-CDC-INFO (800-232-4636) TTY: 888-232-6348
Questions or Problems | Unsubscribe

---------------------------------------
The MCOH-EH List has always been moderated by members of the ACOEM Medical Center Occupational Health Section. It is currently moderated by Joe Fanucchi MD FACOEM.
List membership is free, but only subscribers may post to the list.
To post send messages to: mcoh-eh@mylist.net
To become a subscriber, or to change your subscription options (turn off email while you're on vacation, etc): http://www.mcoh-eh.net
MediTrax / Occupational Health Systems, Inc. provides financial support to ensure the list remains a free resource for the occupational health community.
---------------------------------------
List archives (public): http://mylist.net/archives/mcoh-eh/
---------------------------------------
Send administrative requests to: drjoe@meditrax.com
---------------------------------------
When replying to a message, PLEASE delete all footers, and all messages to which you're NOT replying.

Enass Awad A/Rahman,MD,MPH
Department of Occupational Medicine
Mercy Medical Group
3000 Q Street
Sacramento,CA,95816
Tel: 916-733-3390

"We can enrich the world if we choose to embrace our similarities; we can destroy the world if we choose to emphasize our differences."